The effect of insulin was tested on the rate of synthesis and release of growth hormone in cultured rat anterior pituitary cells. Concentrations of insulin between 10\m=-\9and 10\m=-\7 mol/l (6\p=n-\600 ng/ml or 0\m=.\15\p=n-\15 mu./ml) inhibited synthesis of growth hormone; 10\m=-\8 mol insulin/1 was most effective. The effect was observed after a time-lag of at least 1 h. Insulin at concentrations between 3 \m=x\10\m=-\9 mol/l and 3 \m=x\10\m=-\7 mol/l also inhibited growth hormone secretion in 30 min incubations. The most effective insulin concentration in this case was 3 \ m=x\10\m=-\8 mol/l. Insulin (10\ m=-\ 9\ p=n-\ 10\ m=-\ 7 mol/l) also decreased the intracellular content of prostaglandins E and F. The effect was rapid, reaching a maximum after 30 min. Indomethacin, an inhibitor of prostaglandin synthetase, dramatically lowered the concentration of prostaglandins in the cells within 30 min; growth hormone synthesis was also decreased, but not until after 2 h of incubation. The results suggest that an initial response to insulin treatment is a lowering of intracellular levels of prostaglandins, which may then mediate a decrease in growth hormone synthesis, after a 1\ p=n-\ 2 h delay.
INTRODUCTION
It has previously been shown (Betteridge «fe Wallis, 1973 ) that insulin has a specific stimu¬ latory effect on the synthesis of growth hormone in vitro. These experiments involved the incubation of rat hemipituitary glands with unphysiological levels of bovine insulin. Shenai & Wallis (1974) have shown that insulin at concentrations between 10~9 and 10~e mol/1 inhibits the synthesis of prolactin in vitro. It was the purpose of the present experi¬ ments to investigate the effect of more physiological doses of insulin on the synthesis and release of growth hormone, using dispersed pituitary cells in monolayer culture, and to study possible mechanisms through which insulin might act.
Prostaglandins, especially those of the -series, have been shown to stimulate both the synthesis (MacLeod & Lehmeyer, 1970) and the release (Schofield, 1970) of growth hormone in vitro. They have also been implicated in the mechanism of action of luteinizing hormone releasing hormone on the release of luteinizing hormone from pituitary cells (Barden, Bergeron «fe Betteridge, 1976; .
The role of prostaglandins in the control of growth hormone synthesis and release by insulin has, therefore, been investigated. A preliminary report of some of this work has been published (Betteridge & Wallis, 1977) .
MATERIALS AND METHODS

Materials
Crystalline bovine insulin (24 u./mg) was provided by Burroughs Wellcome Ltd, Becken- ham, Kent. Prostaglandins were provided by Upjohn Pharmaceuticals Ltd, Crawley, Sussex. [5,6,8,11,12,14,15-3H] Prostaglandin E2 (PGE2,140 Ci/mmol), [5,6,8,11,12,14,15-3H] prostaglandin F2o( (PGF^, 130 Ci/mmol) and [4,5-3H] leucine (60 Ci/mmol) were ob¬ tained from the Radiochemical Centre, Amersham, Bucks. Rat growth hormone (NIAMDD-rat-GH-B-3 and NIAMDD-rat-GH-RP-1) and monkey anti-rat growth hormone (NIAMDD anti-rat-GH (Davis, 1964) . The gels were stained, after electrophoresis, with amido black and were destained in 7-5% acetic acid containing 1 mg L-leucine/ml.
The most heavily stained band, which has previously been identified as growth hormone (Lewis, Cheever & VanderLaan, 1965) , was excised, solubilized and counted for radio¬ activity as described by Betteridge «fe Wallis (1973) (1971) . The content of growth hormone in the samples of media was estimated from the standard curve and is expressed in terms of ng NIAMDD-GH-RP-l/ml incubation medium.
Measurement of intracellular prostaglandin content by radioimmunoassay To measure changes in the prostaglandin content of anterior pituitary cells, they were incubated with fresh DMEM for various periods. At the end of the incubation, the medium was removed and the cells were scraped from the dishes in 0-5 ml 0-9% NaCl solution.
The dishes were then washed with 0-5 ml ethanol. These two fractions were combined and sonicated to cause cell lysis and the prostaglandins were extracted with 2 ml ethyl acetate. This extract was dried in vacuo and the residue was resuspended for radioimmuno¬ assay (Barden «fe . The anti-prostaglandin sera were prepared as described previously (Barden «fe centrations of insulin, ranging from 5 IO-10 mol/1 (3 ng/ml) to 10-7 mol/1 (600 ng/ml).
All concentrations of insulin tested from 2 IO-9 mol/1 to higher concentrations signifi¬ cantly (P< 0-02) inhibited synthesis of growth hormone (Fig. 1) . The most effective concen¬ tration was 10-8 mol/1 (78% of control). Above 10-8 mol/1, the effect was found to diminish with increasing concentration up to 10-7 mol/1. It has previously been shown (Betteridge & Wallis, 1973) (Fig. 3) . All the concen¬ trations tested above 10~9 mol/1 significantly (P< 0-02) Effect of various concentrations of insulin on both PGE and PGFa Concentrations of insulin between 10~10 and 10-6 mol/1 were tested for their ability to inhibit the accumulation of both PGE and PGF during a 30 min incubation (Fig. 5) .
The two types of prostaglandin responded in slightly different ways. The PGE content of the cells was significantly lower (P<0-02) in the presence of all concentrations of insulin except 10-10 mol/1. The effect increased with increasing insulin levels up to 10-7 mol/1 (52% of control; P< 0-001), while 10~e mol insulin/1 was slightly less inhibitory. Insulin also significantly inhibited (P<0-05) the accumulation of PGF at concentrations in the range 10_9-10-7 mol/1. The maximum effect was observed in this case with 10-8 mol insulin/1 (53% of control; i><0-05), the effectiveness decreasing as the concentration of insulin was increased to 10~7 mol/1 and above.
Effect of decreased production ofprostaglandin on growth hormone synthesis If the effect of insulin on growth hormone synthesis is mediated by a lowering of the intracellular concentration of prostaglandins, it would be expected that these changes could be mimicked by inhibiting prostaglandin synthesis de novo. Indomethacin at con¬ centrations of 10 or 50 µg/ml significantly lowered the intracellular concentration of both PGE and PGF, as measured by radioimmunoassay. The PGE concentration was reduced to less than 30% of the control value (P<0-01) within 10 min of addition of indo¬ methacin and remained at this level for at least another hour. Levels of PGFa were affected less rapidly, but were significantly lower (58% of control; P<0-01) after 30 and 60 min (37% of control;P< 0-01). When the rate of growth hormone synthesis was measured in the presence of 50 µg indomethacin/ml (Fig. 6) , there was a significant reduction in the incorporation after 3 h (P< 0-02). The addition of indomethacin lowered the rate of growth hormone synthesis by 20% after 3 h, 37% (P<0-01) after 4 h and 30% (P<0-01) after 5 h. The rate of syn¬ thesis over the fifth hour appeared similar in the control and the indomethacin-treated cells.
DISCUSSION
It was initially surprising to find that the concentrations of insulin tested here (10-9-7 mol/1 ; 6-600 ng/ml) inhibited growth hormone synthesis. It has been shown previously 10 (Betteridge «fe Wallis, 1973) that concentrations of insulin above 5 IO-6 mol/1 increase the incorporation of labelled leucine into growth hormone in intact rat hemipituitary glands in vitro. Shenai & Wallis (1974) found that the same insulin concentrations also stimulate the synthesis of prolactin, although they found that lower concentrations (10-9-10~6 mol/1) are inhibitory. It that the insulin used here is bovine and it is possible that lower concentrations of rat insulin might be required to achieve the same results.
The results also show that insulin, at the concentrations used here, has an inhibitory effect on the secretion of growth hormone from these dispersed cells, whereas the higher concentrations tested previously (Betteridge «fe Wallis, 1973) It is possible that there is a physiological interaction between insulin and the somato¬ trophs (cells producing growth hormone). Alternatively, the effect could be due to inter¬ action of insulin with receptors for the somatomedins (Daughaday, Hall, Raben, Salmon, Van den Brande & Van Wyk, 1972) , growth hormone dependent factors which have many properties in common with insulin (Salmon & DuVall, 1970; Hall & Uthne, 1971 ). The latter explanation seems more likely since raised levels of insulin in vivo seem to increase rather than decrease the secretion of growth hormone (Roth, Glick, Yalow & Berson, 1963; Pecile, Müller, Felici, Netti & Cocchi, 1971) Barden, 1975) . We have attempted to measure the effect of insulin on the intracellular concentration of cyclic AMP. The results seem to suggest that insulin is inhibitory, but they are rather variable and inconclusive at present (Betteridge & Wallis, 1977) . It is apparent that the rates of synthesis of growth hormone in the presence of insulin or indomethacin are very close to those of the controls after the third hour, suggesting that the inhibition of growth hormone synthesis by these agents is a transient phenomenon.
Insulin could be affecting intracellular levels of prostaglandins by modulating precursor levels; Betteridge & Wallis (1978) 
